VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce that it is presenting virtually at the Biotech Showcase™ 2022 conference, which is being held virtually January 10-12 and January 17-19, 2022.
Read more at globenewswire.comRakovina Therapeutics Inc. to Present at Biotech Showcase 2022
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
